-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cerebral small blood vessel disease - stroke main reason and dementia associated with cerebrovascular dysfunction
Vascular stroke is associated with decreased cerebrovascular reactivity and impaired cerebrospinal fluid (CSF) dynamics
Recently, a research article was published in Stroke, an authoritative journal in the field of cardiovascular disease.
Participants in the study were randomly assigned to treatment with isosorbide mononitrate alone, cilostazol alone, treatment with isosorbide mononitrate and cilostazol at the same time , or no medication
Isosorbide Mononitrate Isosorbide Mononitrate
Of the 27 participants (mean age 68 ± 7.
Isosorbide mononitrate
It can be seen that although limited by the small sample size, the results of this study prove that it is feasible to use magnetic resonance imaging to measure cerebrovascular function in clinical trials, and treatment with isosorbide mononitrate and cilostazol can improve Cerebrovascular function
Although limited by the small sample size, the results of this study prove that it is feasible to use magnetic resonance imaging to measure cerebrovascular function in clinical trials, and treatment with isosorbide mononitrate and cilostazol can improve cerebrovascular function
Original source:
Gordon W.
